it is believed that ovarian cancer affects mainly nulliparous women (those, who had never given birth). Also, there is an opinion that ovarian cancer may be prevented by taking oral contraceptives. Without a doubt, ovarian cancer (as well as other types of cancer) may be inherited from...
Ovarian cancer is difficult to diagnose because symptoms often do not occur until late in the disease. Symptoms do not occur until the tumor has grown large enough to apply pressure to other organs in the abdomen, or until the cancer has spread to remote organs. The symptoms are nonspecific,...
and in patients who also desire to have children, the uterus and the unaffected ovary are left intact. However, a biopsy is taken from this healthy ovary to rule out the possibility of any cancerous changes in it. Usually, only the cancerous ovary and the fallopian tube of that side...
The women who received the vaccine alongside both chemotherapy drugs showed the best survival rates – 80 per cent of these women were still alive two years later, compared with around 50 per cent of women with similar stages of cancer who received only the drugs. Ovarian cancer bounces back...
Death rates have also fallen an average of 2.8% per year. Like many other cancers, when ovarian cancer is found at an early stage (for example, localized to the ovary or fallopian tube) the average survival rate of five years is very good (about 93%); most women at stage 1 will ...
Ovarian cancer death shock ; Survival rates in Ulster are among worst in Europe
in Phoenix reported today inLancet Oncologythat a new treatment for ovarian cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers recur. In addition, this breakthrough showed a trend in improving survival although these data are not yet mature...
Numerous studies link asbestos exposure to ovarian cancer. Women with a history of asbestos exposure have higher rates of ovarian cancer.
Introduction: To compare long-term survival of primary debulking surgery (PDS) and interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) in patients with advanced ovarian cancer. Methods: Patients who underwent debulking surgery for ovarian cancer between ...
CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC). Patients (n =